Oltmanns D, Dennin D E, Pentz R, Siegers C P
Z Gastroenterol. 1984 Oct;22(10):598-601.
Antipyrine-clearance calculated from a single 24 hrs blood sample following i. v. injection of 1 g was determined in insulin dependent diabetics (n = 20), patients with liver cirrhosis (n = 8), with fatty liver + hepatitis (n = 5) and alcoholics with normal liver morphology (n = 3). Antipyrine-clearance values in normal subjects amounted to 58,7 +/- 4,8 ml/min (means +/- s), in cirrhotics to 11,8 +/- 10,1 ml/min (p less than 0.01), in patients with fatty liver to 43,3 +/- 10,1 ml/min (p less than 0.01), and in alcoholics to 62,5 +/- 18,6 ml/min. In diabetics, diseased for many years, also a decrease in the clearance values was seen (41 +/- 17,5 ml/min; p less than 0.05). 15 out of them were below the 2 s range of normal subjects. Thus, the drug-metabolizing capacity in diabetics seems to be markedly reduced, and drug dosage might have to take account of this fact.
在胰岛素依赖型糖尿病患者(n = 20)、肝硬化患者(n = 8)、脂肪肝合并肝炎患者(n = 5)以及肝脏形态正常的酗酒者(n = 3)中,静脉注射1克安替比林后,根据单次24小时血样计算安替比林清除率。正常受试者的安替比林清除率为58.7±4.8毫升/分钟(均值±标准差),肝硬化患者为11.8±10.1毫升/分钟(p<0.01),脂肪肝患者为43.3±10.1毫升/分钟(p<0.01),酗酒者为62.5±18.6毫升/分钟。在患病多年的糖尿病患者中,清除率值也出现下降(41±17.5毫升/分钟;p<0.05)。其中15例低于正常受试者的2个标准差范围。因此,糖尿病患者的药物代谢能力似乎明显降低,药物剂量可能必须考虑这一事实。